
Bioorganic and medicinal chemistry letters p. 141 - 144 (1999)
Update date:2022-08-03
Topics:
Chu, Guo-Hua
Peters, Amy
Selcer, Kyle W.
Li, Pui-Kai
We report the development of (E)- and (Z)-4-hydroxytamoxifen sulfamates as estrone sulfatase inhibitors, potential therapeutic agents for the treatment of breast cancer. Both compounds competitively inhibit estrone sulfatase isolated from rat liver with apparent Ki of 35.9 μM for (E)-4-hydroxytamoxifen sulfamate and an apparent Ki of >500 μM for the (Z) isomer.
View MoreContact:86-532-68629711 13780605697
Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
NanJing KaiHeng Chemical CO., LTD.
Contact:+86-25-85768391
Address:RM.1704, D, WANDA PLAZA, NO.110, MIDDLE JIANGDONG ROAD, NANJING, CHINA
SHANDONG AONA CHEMICAL CO.,LTD.
Contact:86-532-85762926
Address:LIUYUAN TOWN, ZAOZHUANG CITY, SHANGDONG PROVINCE.
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Doi:10.1021/jo9613601
(1997)Doi:10.1021/ja01207a035
(1946)Doi:10.1016/S0040-4039(96)02075-8
(1996)Doi:10.1016/S0960-894X(99)00187-0
(1999)Doi:10.1016/S0968-0896(02)00612-0
(2003)Doi:10.1021/ja963295i
(1997)